<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> is an important risk factor for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) and in the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, especially in subgroups of the population like those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:chebi fb="4" ids="17855">triglycerides</z:chebi> are generally increased in the postprandial period, the association between postprandial <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (ppTG) levels and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> has not been investigated in north Indian type 2 diabetic subjects known to have a very high prevalence rate of premature CHD and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the role of ppTG levels in <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we examined the correlation between ppTG levels and carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was determined by high resolution B-mode ultrasonography in 86 newly detected type 2 diabetic subjects (1-12 months duration) having good glycemic control (HbA(1C)&lt;7%) and 45 non-diabetic subjects matched according to age and body mass index (BMI) </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, total cholesterol, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were measured after overnight fasting </plain></SENT>
<SENT sid="5" pm="."><plain>Plasma insulin and <z:chebi fb="105" ids="17234">glucose</z:chebi> were also measured 2h and plasma <z:chebi fb="4" ids="17855">triglycerides</z:chebi> 4h after breakfast </plain></SENT>
<SENT sid="6" pm="."><plain>The mean carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in diabetic subjects was higher than those in non-diabetic subjects (0.77+/-0.15 mm versus 0.53+/-0.16 mm, P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Based on the fasting and postprandial <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels, the diabetic subjects were divided into three groups: normo-normo (NN); normo-hyper (NH); hyper-hyper (HH) [NN: fTG&lt;1.70 mmol/L and ppTG&lt;2.30 mmol/L; NH: fTG&lt;1.70 mmol/L and ppTG&gt;2.30 mmol/L; HH: fTG&gt;1.70 mmol/L and ppTG&gt;2.30 mmol/L] </plain></SENT>
<SENT sid="8" pm="."><plain>Carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was significantly increased in the NH (0.79+/-0.09 mm) and HH (0.82+/-0.06 mm) groups compared with the NN group (0.59+/-0.09 mm, P&lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>Although ppTG, age, fasting <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, HOMA-estimated <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, HbA(1C) were <z:hpo ids='HP_0000001'>all</z:hpo> independently correlated with carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, age and ppTG levels had the strongest statistical influence (P&lt;0.002) </plain></SENT>
</text></document>